GlassScriptPhysician profile
James Jenkins
NPI 1861499816
$2,952.47
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $884 · 2020: $814 · 2021: $1,032 · 2022: $224.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $735.86 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $375.47 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $354.97 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $224.67 | 2019-2022 | |
| Lundbeck LLC | $167.36 | 2019-2020 | |
| Abbvie INC. | $133.22 | 2021 | |
| Allergan, INC. | $116.17 | 2020 | |
| Supernus Pharmaceuticals, INC. | $115.05 | 2021-2022 | |
| Bausch Health US, LLC | $111.60 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $86.09 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $80.12 | 2019-2022 | |
| Shire North American Group INC | $67.87 | 2019 | |
| Corium, LLC | $61.02 | 2022 | |
| Vanda Pharmaceuticals INC. | $59.72 | 2020-2022 | |
| Eisai INC. | $50.61 | 2020-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $46.82 | 2021 | |
| Ironshore Pharmaceuticals INC. | $35.06 | 2019 | |
| Adlon Therapeutics L.P. | $32.24 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $30.54 | 2021-2022 | |
| Neuronetics, INC. | $29.70 | 2019 | |
| Alkermes, INC. | $21.88 | 2019 | |
| Almatica Pharma LLC | $16.43 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Jenkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.